Could a simple implant spare men from urinary pain after prostate radiation?

NCT ID NCT05148156

Terminated Symptom relief Sponsor: Northwell Health Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether placing a Urolift device in the prostate before stereotactic body radiation therapy (SBRT) can reduce urinary side effects like frequent urination, pain, and nighttime trips to the bathroom. About 20 men with both prostate cancer and benign prostatic hyperplasia (BPH) will receive the Urolift and then SBRT. Researchers will track symptom scores and quality of life for one year to see if the device helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Urolift device
What this could lead to: If it works, this could offer a way to reduce urinary problems after prostate radiation, improving quality of life for men with BPH.
What could go wrong: This is a very small, early study (20 people) that is currently suspended. It may not show a clear benefit, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Dysuria Nocturia prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATIC HYPERPLASIA

Contacts and locations

Locations

Northwell Health

Syosset, New York, 11791, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.